Genomic, epigenomic, and transcriptomic signatures of prostate cancer between African American and European American patients
C Stevens, A Hightower, SG Buxbaum… - Frontiers in …, 2023 - frontiersin.org
Prostate cancer is the second most common cancer in men in the United States, and racial
disparities are greatly observed in the disease. Specifically, African American (AA) patients …
disparities are greatly observed in the disease. Specifically, African American (AA) patients …
Epigenetic reprogramming during prostate cancer progression: a perspective from development
Conrad Waddington's theory of epigenetic landscape epitomize the process of cell fate and
cellular decision-making during development. Wherein the epigenetic code maintains …
cellular decision-making during development. Wherein the epigenetic code maintains …
[HTML][HTML] LAG3 (LAG-3, CD223) DNA methylation correlates with LAG3 expression by tumor and immune cells, immune cell infiltration, and overall survival in clear cell …
Background Lymphocyte activating 3 (LAG3, LAG-3, CD223) is a promising target for
immune checkpoint inhibition in clear cell renal cell carcinoma (KIRC). The aim of this study …
immune checkpoint inhibition in clear cell renal cell carcinoma (KIRC). The aim of this study …
[HTML][HTML] CTLA4 methylation predicts response to anti–PD-1 and anti–CTLA-4 immunotherapy in melanoma patients
D Goltz, H Gevensleben, TJ Vogt, J Dietrich, C Golletz… - JCI insight, 2018 - ncbi.nlm.nih.gov
Recent years have witnessed the groundbreaking success of immune checkpoint blockage
(ICB) in metastasized malignant melanoma. However, biomarkers predicting the response to …
(ICB) in metastasized malignant melanoma. However, biomarkers predicting the response to …
[HTML][HTML] PD-L1 (CD274) and PD-L2 (PDCD1LG2) promoter methylation is associated with HPV infection and transcriptional repression in head and neck squamous …
A Franzen, TJ Vogt, T Müller, J Dietrich, A Schröck… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Background DNA methylation of the immune checkpoint gene PD-L1 has recently been
shown to be associated with PD-L1 mRNA expression in various malignancies. This study …
shown to be associated with PD-L1 mRNA expression in various malignancies. This study …
Pitx genes in development and disease
Homeobox genes encode sequence-specific transcription factors (SSTFs) that recognize
specific DNA sequences and regulate organogenesis in all eukaryotes. They are essential …
specific DNA sequences and regulate organogenesis in all eukaryotes. They are essential …
[HTML][HTML] Markers of clinical utility in the differential diagnosis and prognosis of prostate cancer
G Kristiansen - Modern Pathology, 2018 - Elsevier
Molecular diagnostics is a rapidly evolving area of surgical pathology, that is gradually
beginning to transform our diagnostical procedures for a variety of tumors. Next to molecular …
beginning to transform our diagnostical procedures for a variety of tumors. Next to molecular …
Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer
S Eickelschulte, AL Riediger, AK Angeles, F Janke… - Cancers, 2022 - mdpi.com
Simple Summary Prostate cancer is a heterogeneous disease and a major cause of cancer
deaths worldwide. The most widely used prostate cancer biomarker, prostate-specific …
deaths worldwide. The most widely used prostate cancer biomarker, prostate-specific …
Advances in prognostic methylation biomarkers for prostate cancer
Simple Summary Prostate cancer is a major cause of cancer-related death in men
worldwide. There is an urgent clinical need for improved prognostic biomarkers to better …
worldwide. There is an urgent clinical need for improved prognostic biomarkers to better …
Identification of deregulated pathways, key regulators, and novel miRNA-mRNA interactions in HPV-mediated transformation
Next to a persistent infection with high-risk human papillomavirus (HPV), molecular changes
are required for the development of cervical cancer. To identify which molecular alterations …
are required for the development of cervical cancer. To identify which molecular alterations …